CABYR Isoforms As Targets for Specific Immunotherapy
Technology Networks,
Oncotarget published " The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and…
CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy.
infosurhoy,
The journal Oncotarget has published “The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal…
CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy
MedicalXpress,
(A) Immunohistochemistry (IHC) staining of testis (positive control). (B) IHC staining of colonic adenocarcinoma.
Oncotarget: CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy
Bioengineer.org,
CABYR expression in tumors was further confirmed by immunohistochemistry Credit: Correspondence to – Richard L.
Oncotarget: CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy
ScienMag,
Oncotarget published “The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold…
Oncotarget: CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy
EurekAlert!,
Oncotarget published "The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold…